Dihydro-β-ionylamin | 43218-71-9

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: Dihydro-β-ionylamin
• 英文别名: 1-methyl-3-(2,6,6-trimethyl-cyclohex-1-enyl)-propylamine；1.1.3-Trimethyl-2-(3-amino-butyl)-cyclohexen-(2)；4-(2,6,6-Trimethylcyclohexen-1-yl)butan-2-amine
• CAS: 43218-71-9
• 化学式: C₁₃H₂₅N
• mdl: MFCD08453508
• 分子量: 195.348
• InChiKey: BGYOBUXTXLLQTA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.846
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  Dihydro-β-ionylamin 在 platinum(IV) oxide 盐酸 、 氢气 作用下， 以 乙醇 为溶剂， 生成 Tetrahydroionylamin
  参考文献：
  名称：

  Primary, secondary and tertiary amines having a spasmolytic effect and method of producing these compounds

  摘要：

  公开号：

  US03046280A1
• 作为产物：
  描述：

  (E)-β-ionone oxime 在 sodium tetrahydroborate 、 cobalt(II) chloride 作用下， 以 甲醇 为溶剂， 生成 Dihydro-β-ionylamin
  参考文献：
  名称：

  Die Synthese von all-trans-Retinylamin und anderen Polyenaminen

  摘要：

  AbstractThe preparation of various polyene phthalimides using the azocarboxylate method is described. The imides are converted into the corresponding amines by reaction with hydrazine. In this way all‐trans‐retinylamine and β‐ionylamine have been obtained.

  DOI：

  10.1002/hlca.19730560523

文献信息

• General and selective synthesis of primary amines using Ni-based homogeneous catalysts
  作者：Kathiravan Murugesan、Zhihong Wei、Vishwas G. Chandrashekhar、Haijun Jiao、Matthias Beller、Rajenahally V. Jagadeesh

  DOI：10.1039/d0sc01084g

  日期：——

  Ni-triphos complex as the first Ni-based homogeneous catalyst for both reductive amination of carbonyl compounds with ammonia and hydrogenation of nitroarenes to prepare all kinds of primary amines. Remarkably, this Ni-complex enabled the synthesis of functionalized and structurally diverse benzylic, heterocyclic and aliphatic linear and branched primary amines as well as aromatic primary amines starting

  通过应用丰富且原子经济的试剂来开发用于工业上相关的胺化和氢化反应的贱金属催化剂，对于经济高效且可持续地合成代表非常重要的化学物质的胺而言，仍然至关重要。尤其是，伯胺的合成至关重要，因为这些化合物用作生产增值精细化学品和散装化学品以及药品，农用化学品和原料的关键前体和主要中间体。在这里，我们报道了一种Ni-triphos络合物，它是第一个用于镍的羰基化合物与氨的还原胺化和硝基芳烃加氢制备各种伯胺的Ni基均相催化剂。值得注意的是，这种镍配合物可以合成功能化且结构多样的苄基，杂环和脂肪族直链和支链伯胺以及芳香族伯胺，是使用氨和分子氢从廉价且易于获得的羰基化合物（醛和酮）和硝基芳烃开始的。这种镍催化的还原胺化方法已用于胺化更复杂的药物和类固醇衍生物。已经对基于Ni-triphos的还原胺化反应进行了详细的DFT计算，结果表明整个反应具有H的内球机理。这种镍催化的还原胺化方法已用于胺化更复杂的药物和
• Reusable Nickel Nanoparticles‐Catalyzed Reductive Amination for Selective Synthesis of Primary Amines
  作者：Kathiravan Murugesan、Matthias Beller、Rajenahally V. Jagadeesh

  DOI：10.1002/anie.201812100

  日期：2019.4

  The preparation of nickel nanoparticles as efficient reductive amination catalysts by pyrolysis of in situ generated Ni‐tartaric acid complex on silica is presented. The resulting stable and reusable Ni‐nanocatalyst enables the synthesis of functionalized and structurally diverse primary benzylic, heterocyclic and aliphatic amines starting from inexpensive and readily available carbonyl compounds and

  本文介绍了通过在二氧化硅上热解原位生成的酒石酸络合物来制备作为高效还原胺化催化剂的镍纳米粒子的方法。所得的稳定且可重复使用的镍纳米催化剂能够在分子氢存在下，从廉价且易于获得的羰基化合物和氨开始，合成功能化且结构多样的伯苄基，杂环和脂肪族胺。应用这种基于镍的胺化方案，可以将-NH 2部分引入结构复杂的化合物中，例如，类固醇衍生物和药物。
• Basic ethers
  申请人：HOFFMANN LA ROCHE

  公开号：US02774766A1

  公开（公告）日：1956-12-18
• DE1007774
  申请人：——

  公开号：——

  公开（公告）日：——
• Formation of domain structure of erythrocyte membrane in Wistar rat fed with CeCl3 per os
  作者：Yi Cheng、Maozi Liu、You Li、Rongchang Li、Chunli Bai、Kui Wang

  DOI：10.1007/bf02884943

  日期：2000.3

  To explore the possibility of absorption of lanthanides via digestive duct and their effects on the membrane structure and permeability of erythrocytes, the fine structure of erythrocyte membrane from Wistar rats, fed for 70 days of daily administration per os with 20 mg CeCl3/kg weight, was imaged by means of atomic force microscopy and FT-IR deconvolution spectra. The results show that, although the erythrocytes maintain the intact shape, the change of secondary structure, aggregation and crosslinking of the protein particles of membrane surface and the enlarged lipid regions lead to the domain structure formation. This structure might be responsible for the increasing permeability of erythrocyte membrane.